| ABC | ATP binding cassette |
| BCRP | Breast cancer resistance protein |
| Cur | Curcumin |
| DOX | Doxorubicin |
| EGFR | Epidermal growth factor receptor |
| ER | Estrogen receptor |
| FDA | Food and drug administration |
| FR | Folate receptor |
| HA | Hyaluronic acid |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hyaluronan receptor |
| IR | Integrin receptor |
| LHRH | Luteinizing hormone-releasing hormone receptor |
| MDR | Multidrug resistance |
| miRNA | microRNA |
| MNPs | Magnetite nanoparticles |
| MRP1 | MDR associated protein |
| NAG | N-acetyl-D-glucosamine |
| NLC | Nanostructured lipid carriers |
| P-gp | P-glycoprotein |
| PTX | Paclitaxel |
| siRNA | Small interfering RNA |
| SLN | Solid lipid nanoparticles |
| SNEDDS | Self-nano emulsifying drug delivery system |
| TfR | Transferrin receptor |
| TNBC | Triple-negative breast cancer |
| TPGS | D-α-Tocopheryl polyethylene glycol 1000 succinate |
| VIP | Vasoactive intestinal peptide receptor |
| WHO | World Health Organization |